7 results on '"Green, Beverly B."'
Search Results
2. Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH)
- Author
-
Green, Beverly B, Anderson, Melissa L, Chubak, Jessica, Baldwin, Laura Mae, Tuzzio, Leah, Catz, Sheryl, Cole, Alison, and Vernon, Sally W
- Subjects
Washington ,Male ,Colon Cancer ,Prevention ,Clinical Trials and Supportive Activities ,Medical Home ,Middle Aged ,Health Services ,Specimen Handling ,Colo-Rectal Cancer ,Good Health and Well Being ,Clinical Research ,Patient-Centered Care ,General & Internal Medicine ,Public Health and Health Services ,Humans ,Female ,Colorectal Neoplasms ,Digestive Diseases ,Early Detection of Cancer ,Cancer Screening ,Aged ,Cancer - Abstract
ObjectiveThe patient-centered medical home (PCMH) includes comprehensive chronic illness and preventive services, including identifying patients who are overdue for colorectal cancer screening (CRCS). The association between PCMH implementation and CRCS during the Systems of Support to Increase Colorectal Cancer Screening Trial (SOS) is described.MethodsThe SOS enrolled 4664 patients from 21 clinics from August 2008 to November 2009. Patients were randomized to usual care, mailed fecal kits, kits plus brief assistance, or kits plus assistance and navigation. A PCMH model that included a workflow for facilitating CRCS was implemented at all study clinics in late 2009. Patients enrolled early had little exposure to the PCMH, whereas patients enrolled later were exposed during most of their first year in the trial. Logistic regression models were used to assess the association between PCMH exposure and CRCS.ResultsUsual care patients with ≥8 months in the PCMH had higher CRCS rates than those with ≤4 months in the PCMH (adjusted difference, 10.1%; 95% confidence interval, 5.7-14.6). SOS interventions led to significant increases in CRCS, but the magnitude of effect was attenuated by exposure to the PCMH (P for interaction = .01).ConclusionExposure to a PCMH was associated with higher CRCS rates. Automated mailed and centrally delivered stepped interventions increased CRCS rates, even in the presence of a PCMH.
- Published
- 2016
3. e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk
- Author
-
Green, Beverly B, Anderson, Melissa L, Cook, Andrea J, Catz, Sheryl, Fishman, Paul A, McClure, Jennifer B, and Reid, Robert J
- Subjects
Adult ,Male ,Aging ,Health Personnel ,Clinical Trials and Supportive Activities ,Blood Pressure ,Cardiovascular ,Medical and Health Sciences ,Education ,Patient Education as Topic ,Blood Pressure Monitoring ,Risk Factors ,Clinical Research ,Weight Loss ,Ambulatory ,Behavioral and Social Science ,Humans ,Antihypertensive Agents ,Aged ,Hypolipidemic Agents ,Nutrition ,Patient Care Team ,Internet ,Prevention ,Middle Aged ,Health Services ,Diet ,Heart Disease ,Good Health and Well Being ,Cardiovascular Diseases ,Patient Satisfaction ,Hypertension ,Female ,Patient Safety ,Public Health - Abstract
BackgroundPharmacist- or nurse-led team care decreases patient blood pressure (BP) and cardiovascular disease (CVD) risk.PurposeTo evaluate whether a Web-based dietitian-led (WD) team care intervention was feasible and resulted in decreased BP, CVD risk, and weight compared to usual care (UC).MethodsElectronic health record (EHR) data identified patients aged 30-69 years with BMI >26, elevated BP, and 10%-25% 10-year Framingham CVD risk who were registered patient website users. Patients with uncontrolled BP at screening were randomized to UC or WD, which included a home BP monitor, scale, and dietitian team care. WD participants had a single in-person dietitian visit to obtain baseline information and create a plan to reduce CVD risk. Planned follow-up occurred via secure messaging to report BP, weight, and fruit and vegetable intake and receive ongoing feedback. If needed, dietitians encouraged patients and their physicians to intensify antihypertensive and lipid-lowering medications. Primary outcomes were change in systolic BP and weight loss ≥4 kg at 6 months. Feasibility outcomes included intervention utilization and satisfaction.ResultsBetween 2010 and 2011, a total of 90 of 101 participants completed 6-month follow-ups. The WD group had higher rates of secure messaging utilization and patient satisfaction. The WD group lost significantly more weight than the UC group (adjusted net difference=-3.2 kg, 95% CI=-5.0, -1.5, p
- Published
- 2014
4. Challenges and possible solutions to colorectal cancer screening for the underserved
- Author
-
Gupta, Samir, Sussman, Daniel A, Doubeni, Chyke A, Anderson, Daniel S, Day, Lukejohn, Deshpande, Amar R, Elmunzer, B Joseph, Laiyemo, Adeyinka O, Mendez, Jeanette, Somsouk, Ma, Allison, James, Bhuket, Taft, Geng, Zhuo, Green, Beverly B, Itzkowitz, Steven H, and Martinez, Maria Elena
- Subjects
Adult ,Male ,Aging ,Consensus ,Oncology and Carcinogenesis ,Medically Underserved Area ,Emigrants and Immigrants ,Clinical Research ,Humans ,Mass Screening ,Oncology & Carcinogenesis ,Healthcare Disparities ,Sigmoidoscopy ,Minority Groups ,Early Detection of Cancer ,Aged ,Quality of Health Care ,Randomized Controlled Trials as Topic ,Cancer ,Medically Uninsured ,screening and diagnosis ,Medicaid ,Incidence ,Prevention ,Colonoscopy ,Middle Aged ,Health Services ,United States ,Colo-Rectal Cancer ,Detection ,Good Health and Well Being ,Occult Blood ,Female ,4.4 Population screening ,Colorectal Neoplasms ,Digestive Diseases - Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. CRC incidence and mortality can be reduced through screening. However, in the United States, screening participation remains suboptimal, particularly among underserved populations such as the uninsured, recent immigrants, and racial/ethnic minority groups. Increasing screening rates among underserved populations will reduce the US burden of CRC. In this commentary focusing on underserved populations, we highlight the public health impact of CRC screening, list key challenges to screening the underserved, and review promising approaches to boost screening rates. We identify four key policy and research priorities to increase screening among underserved populations: 1) actively promote the message, "the best test is the one that gets done"; 2) develop and implement methods to identify unscreened individuals within underserved population groups for screening interventions; 3) develop and implement approaches for organized screening delivery; and 4) fund and enhance programs and policies that provide access to screening, diagnostic follow-up, and CRC treatment for underserved populations. This commentary represents the consensus of a diverse group of experts in cancer control and prevention, epidemiology, gastroenterology, and primary care from across the country who formed the Coalition to Boost Screening among the Underserved in the United States. The group was organized and held its first annual working group meeting in conjunction with the World Endoscopy Organization's annual Colorectal Cancer Screening Committee meeting during Digestive Disease Week 2012 in San Diego, California.
- Published
- 2014
5. Improving BP control through electronic communications: an economic evaluation
- Author
-
Fishman, Paul A, Cook, Andrea J, Anderson, Melissa L, Ralston, James D, Catz, Sheryl L, Carrell, David, Carlson, James, and Green, Beverly B
- Subjects
Male ,Internet ,Comparative Effectiveness Research ,Aging ,Cost-Benefit Analysis ,Clinical Trials and Supportive Activities ,Health Services ,Quality Improvement ,Telemedicine ,Good Health and Well Being ,Cost Effectiveness Research ,Blood Pressure Monitoring ,Clinical Research ,Hypertension ,Ambulatory ,Public Health and Health Services ,Health Policy & Services ,Humans ,Female ,Antihypertensive Agents - Abstract
BackgroundWeb-based collaborative approaches to managing chronic illness show promise for both improving health outcomes and increasing the efficiency of the healthcare system.ObjectiveAnalyze the cost-effectiveness of the Electronic Communications and Home Blood Pressure Monitoring to Improve Blood Pressure Control (e-BP) study, a randomized controlled trial that used a patient-shared electronic medical record, home blood pressure (BP) monitoring, and web-based pharmacist care to improve BP control (
- Published
- 2013
6. Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review
- Author
-
Hamine, Saee, Gerth-Guyette, Emily, Faulx, Dunia, Green, Beverly B, and Ginsburg, Amy Sarah
- Subjects
Lung Diseases ,medicine.medical_specialty ,Telemedicine ,Health Informatics ,Disease ,lcsh:Computer applications to medicine. Medical informatics ,patient compliance ,law.invention ,Quality of life (healthcare) ,Randomized controlled trial ,law ,Health care ,medicine ,Humans ,Disease management (health) ,Intensive care medicine ,mobile health ,mHealth ,Randomized Controlled Trials as Topic ,Original Paper ,Text Messaging ,patient adherence ,business.industry ,lcsh:Public aspects of medicine ,Public health ,Disease Management ,lcsh:RA1-1270 ,cardiovascular diseases ,Treatment Outcome ,diabetes mellitus ,Chronic Disease ,Physical therapy ,lcsh:R858-859.7 ,business - Abstract
BackgroundAdherence to chronic disease management is critical to achieving improved health outcomes, quality of life, and cost-effective health care. As the burden of chronic diseases continues to grow globally, so does the impact of non-adherence. Mobile technologies are increasingly being used in health care and public health practice (mHealth) for patient communication, monitoring, and education, and to facilitate adherence to chronic diseases management. ObjectiveWe conducted a systematic review of the literature to evaluate the effectiveness of mHealth in supporting the adherence of patients to chronic diseases management (“mAdherence”), and the usability, feasibility, and acceptability of mAdherence tools and platforms in chronic disease management among patients and health care providers. MethodsWe searched PubMed, Embase, and EBSCO databases for studies that assessed the role of mAdherence in chronic disease management of diabetes mellitus, cardiovascular disease, and chronic lung diseases from 1980 through May 2014. Outcomes of interest included effect of mHealth on patient adherence to chronic diseases management, disease-specific clinical outcomes after intervention, and the usability, feasibility, and acceptability of mAdherence tools and platforms in chronic disease management among target end-users. ResultsIn all, 107 articles met all inclusion criteria. Short message service was the most commonly used mAdherence tool in 40.2% (43/107) of studies. Usability, feasibility, and acceptability or patient preferences for mAdherence interventions were assessed in 57.9% (62/107) of studies and found to be generally high. A total of 27 studies employed randomized controlled trial (RCT) methods to assess impact on adherence behaviors, and significant improvements were observed in 15 of those studies (56%). Of the 41 RCTs that measured effects on disease-specific clinical outcomes, significant improvements between groups were reported in 16 studies (39%). ConclusionsThere is potential for mHealth tools to better facilitate adherence to chronic disease management, but the evidence supporting its current effectiveness is mixed. Further research should focus on understanding and improving how mHealth tools can overcome specific barriers to adherence.
- Published
- 2015
7. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis
- Author
-
Tucker, Katherine L, Sheppard, James P, Stevens, Richard, Bosworth, Hayden B, Bove, Alfred, Bray, Emma P, Earle, Kenneth, George, Johnson, Godwin, Marshall, Green, Beverly B, Hebert, Paul, Hobbs, FD Richard, Kantola, Ilkka, Kerry, Sally M, Leiva, Alfonso, Magid, David J, Mant, Jonathan, Margolis, Karen L, McKinstry, Brian, McLaughlin, Mary Ann, Omboni, Stefano, Ogedegbe, Olugbenga, Parati, Gianfranco, Qamar, Nashat, Tabaei, Bahman P, Varis, Juha, Verberk, Willem J, Wakefield, Bonnie J, and McManus, Richard J
- Subjects
Patient Education as Topic ,Hypertension ,Humans ,Blood Pressure ,Blood Pressure Monitoring, Ambulatory ,10. No inequality ,Life Style ,Antihypertensive Agents ,3. Good health ,Randomized Controlled Trials as Topic - Abstract
BACKGROUND: Self-monitoring of blood pressure (BP) appears to reduce BP in hypertension but important questions remain regarding effective implementation and which groups may benefit most. This individual patient data (IPD) meta-analysis was performed to better understand the effectiveness of BP self-monitoring to lower BP and control hypertension. METHODS AND FINDINGS: Medline, Embase, and the Cochrane Library were searched for randomised trials comparing self-monitoring to no self-monitoring in hypertensive patients (June 2016). Two reviewers independently assessed articles for eligibility and the authors of eligible trials were approached requesting IPD. Of 2,846 articles in the initial search, 36 were eligible. IPD were provided from 25 trials, including 1 unpublished study. Data for the primary outcomes-change in mean clinic or ambulatory BP and proportion controlled below target at 12 months-were available from 15/19 possible studies (7,138/8,292 [86%] of randomised participants). Overall, self-monitoring was associated with reduced clinic systolic blood pressure (sBP) compared to usual care at 12 months (-3.2 mmHg, [95% CI -4.9, -1.6 mmHg]). However, this effect was strongly influenced by the intensity of co-intervention ranging from no effect with self-monitoring alone (-1.0 mmHg [-3.3, 1.2]), to a 6.1 mmHg (-9.0, -3.2) reduction when monitoring was combined with intensive support. Self-monitoring was most effective in those with fewer antihypertensive medications and higher baseline sBP up to 170 mmHg. No differences in efficacy were seen by sex or by most comorbidities. Ambulatory BP data at 12 months were available from 4 trials (1,478 patients), which assessed self-monitoring with little or no co-intervention. There was no association between self-monitoring and either lower clinic or ambulatory sBP in this group (clinic -0.2 mmHg [-2.2, 1.8]; ambulatory 1.1 mmHg [-0.3, 2.5]). Results for diastolic blood pressure (dBP) were similar. The main limitation of this work was that significant heterogeneity remained. This was at least in part due to different inclusion criteria, self-monitoring regimes, and target BPs in included studies. CONCLUSIONS: Self-monitoring alone is not associated with lower BP or better control, but in conjunction with co-interventions (including systematic medication titration by doctors, pharmacists, or patients; education; or lifestyle counselling) leads to clinically significant BP reduction which persists for at least 12 months. The implementation of self-monitoring in hypertension should be accompanied by such co-interventions.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.